Gyorgy Keseru's Biography

Gyorgy Keseru, Scientific Advisor, Hungarian Academy of Sciences

Dr György M. Keseru obtained his Ph.D. at Budapest, Hungary and joined Sanofi-Aventis CHINOIN heading a chemistry research lab. He moved to Gedeon Richter in 1999 as the Head of Computer-aided Drug Discovery. He earned D.Sc. from the Hungarian Academy of Science in 2003 and he was invited for a research professorship at the Budapest University of Technology and Economics. Since 2007 he was appointed as the Head of Discovery Chemistry at Gedeon Richter. He served as a director general of the Research Centre for Natural Sciences (RCNS) at the Hungarian Academy of Sciences. He contributed to the discovery of the antipsychotic Vraylar® (RGH-188, cariprazine) that has been approved by the US FDA and EMA and marketed from 2016. From 2015 he is heading the Medicinal Chemistry Research Group at RCNS. His research interests include medicinal chemistry and drug design. He has published over 200 papers and more than 10 books and book chapters.